Riskpilot← Back to searchSign inGet full accessMedWay AB
ABActiveOrg 5569018921Gumshornsgatan 7 2 TrHospital activities · NACE 8610Est. 20120 employees
Revenue 2025
SEK 94K
-24% vs 2024
EBITDA margin
45.1%
-51% vs 2024
Equity ratio
91.0%
Financial strength
Net profit 2025
SEK 49K
+87% vs 2024
| Revenue | SEK 94K | -24% |
| EBITDA | SEK 42K | -51% |
| Net profit | SEK 49K | +87% |
| Total assets | SEK 495K | +22% |
| Equity | SEK 450K | +19% |
| Employees | 0 | — |
Legal name
MedWay AB
Org number
5569018921
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
27 augusti 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsultation och behandling, forskning, utveckling, undervisning inom neurovetenskap, neurologi och neurokirurgi
Address
Gumshornsgatan 7 2 Tr
Email
mikael.svensson@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 177 | 204 | 204 | 125 | 94 |
| Staff expenses | — | — | −1 | −1 | −1 |
| EBITDA | 114 | 151 | 56 | 87 | 42 |
| Depreciation & amort. | −6 | −32 | −51 | −55 | 20 |
| EBIT | 108 | 118 | 5 | 32 | 62 |
| Net financials | — | −0 | 1 | 1 | 0 |
| Profit before tax | 108 | 118 | 7 | 34 | 63 |
| Tax | −22 | −25 | −1 | −8 | −14 |
| Net profit | 86 | 93 | 5 | 26 | 49 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 303 | 384 | 361 | 404 | 495 |
| Equity | 253 | 347 | 352 | 378 | 450 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 49 | 37 | 9 | 26 | 45 |
| Total debt | 49 | 37 | 9 | 26 | 45 |
EBITDA margin
45.1%
This company
15.8%
Market median
+185% vs market
20212025
Equity ratio
91.0%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
10.8%
This company
18.4%
Market median
+41% vs market
20212025
Net profit margin
51.7%
This company
8.1%
Market median
+538% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MA Chief Executive Officer | Chief Executive Officer | 2022 |
OA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedWay AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikael Anders Johan Svensson | Chief Executive Officer | 0 companies |
| Oscar Axel Svensson | Deputy Chief Executive Officer | 0 companies |